SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9.89 |
| Enterprise Value ($M) | 4.48 |
| Book Value ($M) | -2.03 |
| Book Value / Share | -0.56 |
| Price / Book | -4.87 |
| NCAV ($M) | -2.05 |
| NCAV / Share | -0.56 |
| Price / NCAV | -4.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -6.21 |
| Return on Equity (ROE) | -13.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.07 |
| Current Ratio | 1.07 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.92 |
| Assets | 8.94 |
| Liabilities | 10.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Ikarian Capital, LLC | 9.99 | ||
| 13G | Alyeska Investment Group, L.P. | 9.90 | ||
| 13G | Ayrton Capital LLC | 9.90 | ||
| 13D/A | Orbimed Advisors Llc | 19.90 | 25.65 | |
| 13G | Perceptive Advisors Llc | 9.90 | ||
| 13D | Viriom, Inc. | 11.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,729 | 14,930 | 18.28 | |
| 1,606 | 8,009 | 20.05 | |
| 5,918 | 30,470 | 19.42 | |
| 3,774 | 15,691 | 24.05 | |
| 5,667 | 43,372 | 13.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TNFA – TNF Pharmaceuticals, Inc. | TNXP – Tonix Pharmaceuticals Holding Corp. |
| TPST – Tempest Therapeutics, Inc. | TTNP – Titan Pharmaceuticals, Inc. |
| UNCY – Unicycive Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io